This document is provided strictly for educational and informational purposes related to laboratory research. The compounds referenced within this material are research chemicals intended for laboratory research use only and are not approved for human or veterinary consumption. The information contained in this document does not constitute medical advice, treatment recommendations, or dosing guidance for humans or animals. Any protocols, dosing schedules, or procedures described are derived from published or investigational research models and are presented solely for the purpose of scientific reference and discussion. Many compounds referenced in this document are investigational substances that have not been approved by the U.S. Food and Drug Administration (FDA). By accessing this document, the reader acknowledges the information is for research and educational reference only.
Tesamorelin targets visceral fat reduction via GHRH stimulation. Ipamorelin adds a complementary GH pulse through GHRP pathways. Together this stack maximizes GH output for enhanced fat loss — particularly abdominal fat — body recomposition, and recovery.
🧪 Reconstitution
Use 1ml (1cc) each of BAC water.
🌡️ Keep peptides refrigerated at 36–46°F (2–8°C) at all times.
Tesamorelin: 0.5mg/day (5 units), 30 min before bed; 5 on, 2 off, 8 weeks max
Ipamorelin: 200–300mcg per injection, before bed (stack with TESA dose)
Method: Subcutaneous injection
⚠️ Side Effects
Common / Not Concerning
Mild water retention
Injection site reactions
Mild joint stiffness or aches
Monitor Closely
Blood glucose — GH release can affect insulin sensitivity
Severe fluid retention or vision changes — stop and consult
For research and educational purposes only. Not medical advice. Always consult a licensed healthcare professional.